NCT02182557

WAL 801 CL Dry Syrup in Paediatric Atopic Dermatitis Patients

Phase III Double-Blind Comparative Study of WAL 801 CL Dry Syrup in Paediatric Atopic Dermatitis Patients

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 162 (actual)
• Sponsor: Boehringer Ingelheim · Industry
• Sex: All
• Age: 15 Years
• Healthy volunteers: Not accepted

Summary

Study to investigate the safety and efficacy of WAL 801 CL Dry Syrup on pruritus associated with paediatric atopic dermatitis in comparison with that of Ketotifen Fumarate Dry Syrup and to confirm the appropriateness of dosage of WAL801 Dry Syrup.

Conditions

• Dermatitis, Atopic

Interventions

Type	Name	Description
DRUG	WAL 801 CL Dry Syrup
DRUG	Ketotifen Fumarate Dry Syrup
DRUG	WAL 801 CL Dry Syrup placebo
DRUG	Ketotifen Fumarate Dry Syrup placebo

Timeline

• Start date: 2001-06-01
• Primary completion: 2002-01-01
• First posted: 2014-07-08
• Last updated: 2014-07-14